US FDA accepts regulatory submission for Selumetinib

This article was originally published here

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application

The post US FDA accepts regulatory submission for Selumetinib appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply